The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, R. M.
Right arrow Articles by Wells, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, R. M.
Right arrow Articles by Wells, A. D.
The Journal of Immunology, 2005, 174: 4639-4646.
Copyright © 2005 by The American Association of Immunologists

Signals from CD28 Induce Stable Epigenetic Modification of the IL-2 Promoter1

Rajan M. Thomas*, Ling Gao* and Andrew D. Wells2,*,{dagger}

* Joseph Stokes, Jr., Research Institute, The Children’s Hospital of Philadelphia and {dagger} University of Pennsylvania School of Medicine, Philadelphia, PA 19104

CD28 costimulation controls multiple aspects of T cell function, including the expression of proinflammatory cytokine genes. One of these genes encodes IL-2, a growth factor that influences T cell proliferation, survival, and differentiation. Antigenic signaling in the absence of CD28 costimulation leads to anergy, a mechanism of tolerance that renders CD4+ T cells unable to produce IL-2. The molecular mechanisms by which CD28 costimulatory signals induce gene expression are not fully understood. In eukaryotic cells, the expression of many genes is influenced by their physical structure at the level of DNA methylation and local chromatin remodeling. To address whether these epigenetic mechanisms are operative during CD28-dependent gene expression in CD4+ T cells, we compared cytosine methylation and chromatin structure at the IL-2 locus in fully activated CD4+ effector T cells and CD4+ T cells rendered anergic by TCR ligation in the absence of CD28 costimulation. Costimulation through CD28 led to marked, stable histone acetylation and loss of cytosine methylation at the IL-2 promoter/enhancer. This was accompanied by extensive remodeling of the chromatin in this region to a structure highly accessible to DNA binding proteins. Conversely, TCR activation in the absence of CD28 costimulation was not sufficient to promote histone acetylation or cytosine demethylation, and the IL-2 promoter/enhancer in anergic cells remained completely inaccessible. These data suggest that CD28 may function through epigenetic mechanisms to promote CD4+ T cell responses.


Related articles in The JI:

IN THIS ISSUE

The JI 2005 174: 4449-4450. [Full Text]  



This article has been cited by other articles:


Home page
BloodHome page
G. Lal and J. S. Bromberg
Epigenetic mechanisms of regulation of Foxp3 expression
Blood, October 29, 2009; 114(18): 3727 - 3735.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. D. Wells
New Insights into the Molecular Basis of T Cell Anergy: Anergy Factors, Avoidance Sensors, and Epigenetic Imprinting
J. Immunol., June 15, 2009; 182(12): 7331 - 7341.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Nayak, J. Glockner-Pagel, M. Vaeth, J. E. Schumann, M. Buttmann, T. Bopp, E. Schmitt, E. Serfling, and F. Berberich-Siebelt
Sumoylation of the Transcription Factor NFATc1 Leads to Its Subnuclear Relocalization and Interleukin-2 Repression by Histone Deacetylase
J. Biol. Chem., April 17, 2009; 284(16): 10935 - 10946.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Sun, Q. Xie, J. Ma, S. Yang, Q. Chen, and A. Hong
Nuclear Factor Y Is Required for Basal Activation and Chromatin Accessibility of Fibroblast Growth Factor Receptor 2 Promoter in Osteoblast-like Cells
J. Biol. Chem., January 30, 2009; 284(5): 3136 - 3147.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Sgouroudis, A. Albanese, and C. A. Piccirillo
Impact of Protective IL-2 Allelic Variants on CD4+Foxp3+ Regulatory T Cell Function In Situ and Resistance to Autoimmune Diabetes in NOD Mice
J. Immunol., November 1, 2008; 181(9): 6283 - 6292.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. C. McKarns and R. H. Schwartz
Biphasic Regulation of Il2 Transcription in CD4+ T Cells: Roles for TNF-{alpha} Receptor Signaling and Chromatin Structure
J. Immunol., July 15, 2008; 181(2): 1272 - 1281.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Thomas, N. Chunder, C. Chen, S. E. Umetsu, S. Winandy, and A. D. Wells
Ikaros Enforces the Costimulatory Requirement for IL2 Gene Expression and Is Required for Anergy Induction in CD4+ T Lymphocytes
J. Immunol., December 1, 2007; 179(11): 7305 - 7315.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. T. Kim, P. E. Fields, and R. A. Flavell
Demethylation of a specific hypersensitive site in the Th2 locus control region
PNAS, October 23, 2007; 104(43): 17052 - 17057.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. B. Day, W. Zeng, P. C. Doherty, D. C. Jackson, K. Kedzierska, and S. J. Turner
The Context of Epitope Presentation Can Influence Functional Quality of Recalled Influenza A Virus-Specific Memory CD8+ T Cells
J. Immunol., August 15, 2007; 179(4): 2187 - 2194.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H.-P. Kim and W. J. Leonard
CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation
J. Exp. Med., July 9, 2007; 204(7): 1543 - 1551.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Bostik, E. S. Noble, S. T. Stephenson, F. Villinger, and A. A. Ansari
CD4+ T Cells from Simian Immunodeficiency Virus Disease-Resistant Sooty Mangabeys Produce More IL-2 Than Cells from Disease-Susceptible Species: Involvement of p300 and CREB at the Proximal IL-2 Promoter in IL-2 Up-Regulation
J. Immunol., June 15, 2007; 178(12): 7720 - 7729.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. D. Powell
Bringing IL-2 down to earth
Blood, April 1, 2007; 109(7): 2671 - 2672.
[Full Text] [PDF]


Home page
BloodHome page
S. Bandyopadhyay, M. Dure, M. Paroder, N. Soto-Nieves, I. Puga, and F. Macian
Interleukin 2 gene transcription is regulated by Ikaros-induced changes in histone acetylation in anergic T cells
Blood, April 1, 2007; 109(7): 2878 - 2886.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Wang, R. A. Barke, and S. Roy
Transcriptional and Epigenetic Regulation of Interleukin-2 Gene in Activated T Cells by Morphine
J. Biol. Chem., March 9, 2007; 282(10): 7164 - 7171.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Chen, E. A. Rowell, R. M. Thomas, W. W. Hancock, and A. D. Wells
Transcriptional Regulation by Foxp3 Is Associated with Direct Promoter Occupancy and Modulation of Histone Acetylation
J. Biol. Chem., December 1, 2006; 281(48): 36828 - 36834.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. K. Northrop, R. M. Thomas, A. D. Wells, and H. Shen
Epigenetic Remodeling of the IL-2 and IFN-{gamma} Loci in Memory CD8 T Cells Is Influenced by CD4 T Cells
J. Immunol., July 15, 2006; 177(2): 1062 - 1069.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.